Eton Pharmaceuticals (ETON) Common Equity (2017 - 2026)
Eton Pharmaceuticals (ETON) posted Common Equity of $26.2 million for Q4 2025, up 13.09% sequentially from $23.1 million in Q3 2025, and up 7.07% YoY from $24.4 million in Q4 2024.
Eton Pharmaceuticals (ETON) Common Equity (2017 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Common Equity for 9 years, with the latest figure at $26.2 million in Q4 2025.
- Quarterly Common Equity rose 7.07% year-over-year to $26.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.2 million (up 7.07% YoY) and the FY2025 annual result came in at $26.2 million, up 7.07% from the prior year.
- Common Equity advanced to $26.2 million in Q4 2025 per ETON's latest filing, from $23.1 million in the prior quarter.
- Over five years, Common Equity peaked at $26.2 million in Q4 2025 and troughed at $11.2 million in Q3 2022.
- A 5-year average of $17.7 million and a median of $16.4 million in 2023 frame the typical range for Common Equity.
- The sharpest annual moves came in 2021 and 2022: Common Equity soared 1028.24% in 2021, then tumbled 37.91% in 2022.
- Over 5 years, Common Equity stood at $17.6 million in 2021, then slipped by 25.82% to $13.1 million in 2022, then advanced by 18.34% to $15.5 million in 2023, then surged by 57.83% to $24.4 million in 2024, then increased by 7.07% to $26.2 million in 2025.
- According to Business Quant data, Common Equity over the past three periods registered $26.2 million, $23.1 million, and $24.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 46.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.59 Mn |
| Dec 31, 2025 | 26.15 Mn |
| Sep 30, 2025 | 23.13 Mn |
| Jun 30, 2025 | 23.96 Mn |
| Mar 31, 2025 | 24.45 Mn |
| Dec 31, 2024 | 24.43 Mn |
| Sep 30, 2024 | 15.98 Mn |
| Jun 30, 2024 | 13.46 Mn |
| Mar 31, 2024 | 15.49 Mn |
| Dec 31, 2023 | 15.48 Mn |
| Sep 30, 2023 | 16.89 Mn |
| Jun 30, 2023 | 16.73 Mn |
| Mar 31, 2023 | 11.24 Mn |
| Dec 31, 2022 | 13.08 Mn |
| Sep 30, 2022 | 11.18 Mn |
| Jun 30, 2022 | 13.24 Mn |
| Mar 31, 2022 | 13.38 Mn |
| Dec 31, 2021 | 17.63 Mn |
| Sep 30, 2021 | 15.66 Mn |
| Jun 30, 2021 | 20.74 Mn |